Highlights + Events

Recent Publications

Pasley S, Zylberberg C, Matosevic S. Natural killer-92 cells maintain cytotoxic activity after long-term cryopreservation in new DMSO-free media. Immunology Letters, 2017, In press.

 

Zylberberg C and Matosevic S. Bioengineered liposome-scaffold composites as therapeutic delivery systems. 2017, Therapeutic Delivery, 8(6):425-445.

 

Zylberberg C, Gaskill K, Pasley S, Matosevic S. Engineering liposomal nanoparticles for targeted gene therapy. Gene Therapy, 2017, 24(8):441-452.

 

Zylberberg C and Matosevic S. Bioengineered liposome-scaffold composites as therapeutic delivery systems. Therapeutic Delivery, 2017, 8(6):425-445.

 

Zylberberg C, Gaskill K, Pasley S, Matosevic S. Engineering liposomal nanoparticles for targeted gene therapy. 2017, Gene Therapy, 1-12.

 

Haddock R, Lin-Gibson S, Lumelsky N, McFarland R, Roy K, Saha K, Zhang J, Zylberberg C. Manufacturing Cell Therapies: The Paradigm Shift in Health Care of This Century. 2017, National Academy of Medicine, 1-13.

 

Buckler L, Kunkel E, Thompson M, Ehrhardt R. Technological developments for small-scale downstream processing of cell therapies. 2016, Cytotherapy, 18(3):301-306.

http://www.celltherapyjournal.org/article/S1465-3249(15)01164-0/fulltext

 

Zylberberg C, Matosevic S. Pharmaceutical liposomal drug delivery: a review of new delivery systems and a look at the regulatory landscape. 2016, Drug delivery, 23(9):3319-3329.

http://www.tandfonline.com/doi/full/10.1080/10717544.2016.1177136

 

Solomon J, Csontos L, Clarke D, Bonvhadi M, Zylberberg C, McNiece I, Kurtzberg J, Bell R, Deans R. Current perspectives on the use of ancillary materials for the manufacture of cellular therapies. 2016, Cytotherapy, 18(1):1-12.

http://www.celltherapyjournal.org/article/S1465-3249(15)01067-1/fulltext

 

Knapinska A, Amar S, He Z, Matosevic S, Zylberberg C, Fields G. Matrix metalloproteinases as reagents for cell isolationEnzyme and Microbial Technology, 2016, 93-94:29-43.

http://www.sciencedirect.com/science/article/pii/S0141022916301387?via%3Dihub

 

Solomon J, Csontos L, Clarke D, Bonyhadi M, Zylberberg C, McNiece I, Kurtzberg J, Bell R, Deans R. Current perspectives on the use of ancillary materials for the manufacture of cellular therapies. 2016, Cytotherapy, 18(1):1-12.

 

Porat Y, Abraham E, O Karnieli, Nahum S, Woda J, Zylberberg C. Critical elements in the development of cell therapy potency assays for ischemic conditions. 2015, Cytotherapy, 17(7):817-831.

http://www.celltherapyjournal.org/article/S1465-3249(14)00855-X/fulltext

 

Abbott S, MacKay G, Durdy M, Solomon S, Zylberberg C. Twenty years of the International Society for Cellular Therapies: the past, present and future of cellular therapy clinical development. 2014, Cytotherapy, 16(4):S112-S119.

http://www.celltherapyjournal.org/article/S1465-3249(14)00005-X/fulltext

 

Assal RE, Guven S, Gurkan UA, et al. Bio-inspired Cryo-ink Preserves Red Blood Cell Phenotype and Function during Nanoliter Vitrification. 2014, Advanced materials, 26(33):5815-5822.